These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 35691795)

  • 21. Connective Tissue Growth Factor Is Overexpressed in Explant Lung Tissue and Broncho-Alveolar Lavage in Transplant-Related Pulmonary Fibrosis.
    Vanstapel A; Goldschmeding R; Broekhuizen R; Nguyen T; Sacreas A; Kaes J; Heigl T; Verleden SE; De Zutter A; Verleden G; Weynand B; Verbeken E; Ceulemans LJ; Van Raemdonck DE; Neyrinck AP; Schoemans HM; Vanaudenaerde BM; Vos R
    Front Immunol; 2021; 12():661761. PubMed ID: 34122421
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Zbtb7a induction in alveolar macrophages is implicated in anti-HLA-mediated lung allograft rejection.
    Nayak DK; Zhou F; Xu M; Huang J; Tsuji M; Yu J; Hachem R; Gelman AE; Bremner RM; Smith MA; Mohanakumar T
    Sci Transl Med; 2017 Jul; 9(398):. PubMed ID: 28701473
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Influence of azithromycin and allograft rejection on the post-lung transplant microbiota.
    Spence CD; Vanaudenaerde B; Einarsson GG; Mcdonough J; Lee AJ; Johnston E; Verleden GM; Elborn JS; Dupont LJ; Van Herck A; Gilpin DF; Vos R; Tunney MM; Verleden SE
    J Heart Lung Transplant; 2020 Feb; 39(2):176-183. PubMed ID: 31812487
    [TBL] [Abstract][Full Text] [Related]  

  • 24. BALF cytokines in different phenotypes of chronic lung allograft dysfunction in lung transplant patients.
    Berastegui C; Gómez-Ollés S; Sánchez-Vidaurre S; Culebras M; Monforte V; López-Meseguer M; Bravo C; Ramon MA; Romero L; Sole J; Cruz MJ; Román A
    Clin Transplant; 2017 Mar; 31(3):. PubMed ID: 28008659
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Systems prediction of chronic lung allograft dysfunction: Results and perspectives from the Cohort of Lung Transplantation and Systems prediction of Chronic Lung Allograft Dysfunction cohorts.
    Pison C; Tissot A; Bernasconi E; Royer PJ; Roux A; Koutsokera A; Coiffard B; Renaud-Picard B; Le Pavec J; Mordant P; Demant X; Villeneuve T; Mornex JF; Nemska S; Frossard N; Brugière O; Siroux V; Marsland BJ; Foureau A; Botturi K; Durand E; Pellet J; Danger R; Auffray C; Brouard S; Nicod L; Magnan A;
    Front Med (Lausanne); 2023; 10():1126697. PubMed ID: 36968829
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Association between the renin-angiotensin system and chronic lung allograft dysfunction.
    Berra G; Farkona S; Mohammed-Ali Z; Kotlyar M; Levy L; Clotet-Freixas S; Ly P; Renaud-Picard B; Zehong G; Daigneault T; Duong A; Batruch I; Jurisica I; Konvalinka A; Martinu T
    Eur Respir J; 2021 Oct; 58(4):. PubMed ID: 33863738
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Early posttransplant reductions in club cell secretory protein associate with future risk for chronic allograft dysfunction in lung recipients: results from a multicenter study.
    Todd JL; Weber JM; Kelly FL; Neely ML; Nagler A; Carmack D; Frankel CW; Brass DM; Belperio JA; Budev MM; Hartwig MG; Martinu T; Reynolds JM; Shah PD; Singer LG; Snyder LD; Weigt SS; Palmer SM
    J Heart Lung Transplant; 2023 Jun; 42(6):741-749. PubMed ID: 36941179
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Increased alveolar macrophage nuclear factor-kappa B activation and macrophage inhibitory protein-1alpha levels in lung transplant patients.
    Farver CF; Raychaudhuri B; Malur A; Drazba J; Maurer J; Tubbs R; Mehta AC; Schilz R; Thomassen MJ
    Transplantation; 2000 Dec; 70(11):1599-603. PubMed ID: 11152221
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Lung allograft dysfunction correlates with gamma-interferon gene expression in bronchoalveolar lavage.
    Ross DJ; Moudgil A; Bagga A; Toyoda M; Marchevsky AM; Kass RM; Jordan SC
    J Heart Lung Transplant; 1999 Jul; 18(7):627-36. PubMed ID: 10452338
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Fibroproliferation in chronic lung allograft dysfunction: Association of mesenchymal cells in bronchoalveolar lavage with phenotypes and survival.
    Combs MP; Xia M; Wheeler DS; Belloli EA; Walker NM; Braeuer RR; Lyu DM; Murray S; Lama VN
    J Heart Lung Transplant; 2020 Aug; 39(8):815-823. PubMed ID: 32360292
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Diagnostic value of plasma and bronchoalveolar lavage samples in acute lung allograft rejection: differential cytology.
    Speck NE; Schuurmans MM; Murer C; Benden C; Huber LC
    Respir Res; 2016 Jun; 17(1):74. PubMed ID: 27323950
    [TBL] [Abstract][Full Text] [Related]  

  • 32. CXCR3 ligands are associated with the continuum of diffuse alveolar damage to chronic lung allograft dysfunction.
    Shino MY; Weigt SS; Li N; Palchevskiy V; Derhovanessian A; Saggar R; Sayah DM; Gregson AL; Fishbein MC; Ardehali A; Ross DJ; Lynch JP; Elashoff RM; Belperio JA
    Am J Respir Crit Care Med; 2013 Nov; 188(9):1117-25. PubMed ID: 24063316
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Upregulation of CD40, CD80, CD83 or CD86 on alveolar macrophages after lung transplantation.
    Nicod LP; Joudrier S; Isler P; Spiliopoulos A; Pache JC
    J Heart Lung Transplant; 2005 Aug; 24(8):1067-75. PubMed ID: 16102442
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Rate of recipient-derived alveolar macrophage development and major histocompatibility complex cross-decoration after lung transplantation in humans.
    Snyder ME; Bondonese A; Craig A; Popescu I; Morrell MR; Myerburg MM; Iasella CJ; Lendermon E; Pilweski J; Johnson B; Kilaru S; Zhang Y; Trejo Bittar HE; Wang X; Sanchez PG; Lakkis F; McDyer J
    Am J Transplant; 2022 Feb; 22(2):574-587. PubMed ID: 34431221
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Gene Expression Profiling of Bronchoalveolar Lavage Cells Preceding a Clinical Diagnosis of Chronic Lung Allograft Dysfunction.
    Weigt SS; Wang X; Palchevskiy V; Gregson AL; Patel N; DerHovanessian A; Shino MY; Sayah DM; Birjandi S; Lynch JP; Saggar R; Ardehali A; Ross DJ; Palmer SM; Elashoff D; Belperio JA
    PLoS One; 2017; 12(1):e0169894. PubMed ID: 28103284
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Immune Checkpoints Expression in Chronic Lung Allograft Rejection.
    Righi I; Vaira V; Morlacchi LC; Croci GA; Rossetti V; Blasi F; Ferrero S; Nosotti M; Rosso L; Clerici M
    Front Immunol; 2021; 12():714132. PubMed ID: 34489963
    [TBL] [Abstract][Full Text] [Related]  

  • 37. MiR-21 in Lung Transplant Recipients With Chronic Lung Allograft Dysfunction.
    Miyahara N; Benazzo A; Oberndorfer F; Iwasaki A; Laszlo V; Döme B; Hoda MA; Jaksch P; Klepetko W; Hoetzenecker K
    Transpl Int; 2021; 35():10184. PubMed ID: 35185369
    [No Abstract]   [Full Text] [Related]  

  • 38. Emergence of inflammatory alveolar macrophages during rejection or infection after lung transplantation.
    Frachon I; Fattal-German M; Magnan A; Cerrina J; Le Roy Ladurie F; Parquin F; Rain B; Lecerf F; Dartevelle P; Emilie D
    Transplantation; 1994 Jun; 57(11):1621-8. PubMed ID: 7516588
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Macrophages in experimental rat lung isografts and allografts: infiltration and proliferation in situ.
    Schmidt A; Sucke J; Fuchs-Moll G; Freitag P; Hirschburger M; Kaufmann A; Garn H; Padberg W; Grau V
    J Leukoc Biol; 2007 Jan; 81(1):186-94. PubMed ID: 17053164
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Symptomatic Respiratory Virus Infection and Chronic Lung Allograft Dysfunction.
    Fisher CE; Preiksaitis CM; Lease ED; Edelman J; Kirby KA; Leisenring WM; Raghu G; Boeckh M; Limaye AP
    Clin Infect Dis; 2016 Feb; 62(3):313-319. PubMed ID: 26565010
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.